156 (PB-063) Poster - Safety of trastuzumab deruxtecan and radiation therapy combination in HER2-positive metastatic breast cancer patients.

Authors :: Visani, L.
Ratosa, I.
Ribnikar, D.
Becherini, C.
Bertini, N.
Bonaparte, I.
Stefanovski, D.
Dobnikar, N.
Desideri, I.
Mattioli, C.
Valzano, M.
Banini, M.
Salvestrini, V.
Bernini, M.
Tommasi, C.
Nori, J.
Orzalesi, L.
Bianchi, S.
Livi, L.
Meattini, I.
Source :: European Journal of Cancer. Mar2024:Supplement 1, Vol. 200, pN.PAG-N.PAG. 1p.
Publication Year :: 2024

Subjects :: *TRASTUZUMAB
*PATIENT safety
*BREAST tumors
*CANCER patients
*CONFERENCES & conventions
*ONCOGENES
*COMBINED modality therapy

Full Text Access

Tools